Jacqueline Iannacone
Psychiatric/Mental Health · Manasquan, NJNPI 1316675531
Payments from drug & device makers
Across 237 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Axsome Therapeutics, Inc.$526
- Alkermes, Inc.$452
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$386
- Otsuka America Pharmaceutical, Inc.$308
- Lundbeck LLC$247
- plus $718 from 12 others
What the payments were for
- Food & beverage$3,737100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,100 |
| Axsome Therapeutics, Inc. | 28 | $526 |
| Alkermes, Inc. | 27 | $452 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $386 |
| Otsuka America Pharmaceutical, Inc. | 13 | $308 |
| Lundbeck LLC | 18 | $247 |
| Supernus Pharmaceuticals, Inc. | 7 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $110 |
| Bausch Health US, LLC | 5 | $87 |
| Corium, LLC | 6 | $87 |
| Teva Pharmaceuticals USA, Inc. | 5 | $75 |
| Neurocrine Biosciences, Inc. | 5 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| Indivior Inc. | 3 | $46 |
| Braeburn Inc. | 2 | $28 |
| Johnson & Johnson | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| OWP Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$122
- ABILIFY MAINTENA$114
How this compares
$3,737 in reported general payments places this provider in the 90th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 15 | $951 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $586 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $584 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $382 |
| Alprazolam | 18 | $273 |
| Aripiprazole | 14 | $228 |
| Gabapentin | 17 | $224 |
| Fluoxetine Hcl | 27 | $207 |
| Buspirone Hcl | 13 | $103 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Manasquan
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
- Marisa SavicOradel$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.